Variant report
Variant | esv3417744 |
---|---|
Chromosome Location | chr8:51029513-51030068 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs551510807 | chr8:51029530-51029531 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs569997042 | chr8:51029537-51029538 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs565270062 | chr8:51029555-51029556 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs117600679 | chr8:51029573-51029574 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs543779583 | chr8:51029596-51029597 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182876853 | chr8:51029602-51029603 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs16914298 | chr8:51029654-51029655 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs529717846 | chr8:51029714-51029715 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs537558149 | chr8:51029771-51029772 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566546290 | chr8:51029773-51029774 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs527523448 | chr8:51029788-51029789 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs16914299 | chr8:51029794-51029795 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs570730567 | chr8:51029799-51029800 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs538153259 | chr8:51029821-51029822 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs368474053 | chr8:51029872-51029873 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs557351264 | chr8:51029896-51029897 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569278244 | chr8:51029923-51029924 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs536342761 | chr8:51029927-51029928 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187513294 | chr8:51029935-51029936 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs17760044 | chr8:51029983-51029984 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs371906680 | chr8:51029994-51029995 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs116656914 | chr8:51030005-51030006 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:51018400-51039600 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
2 | chr8:51028600-51030600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
3 | chr8:51029400-51030200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |